These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26457881)

  • 1. Impact of therapy in a cohort of unselected children with Down Syndrome-associated Acute Lymphoblastic Leukaemia.
    Derouet A; Petit A; Baruchel A; Clavel J; Brethon B; Bertrand Y; Lutz P; Nacka F; Ducassou S
    Br J Haematol; 2016 Sep; 174(6):983-5. PubMed ID: 26457881
    [No Abstract]   [Full Text] [Related]  

  • 2. Poor treatment compliance in children with down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Taskinen M; Zeller B; Björgvinsdóttir H; Hafsteinsdottir S; Schmiegelow K
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):79-80. PubMed ID: 19125098
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wernicke's encephalopathy in a child with Down syndrome, undergoing treatment for acute lymphoblastic leukemia.
    Yıldırım AT; Bilgili G; Akman B; Ovalı GY; Özgüven AA; Gülen H
    Pediatr Int; 2016 Aug; 58(8):757-9. PubMed ID: 27324305
    [No Abstract]   [Full Text] [Related]  

  • 6. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
    Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
    Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced side effects are not due to differences in pharmacokinetics in children with Down syndrome and acute lymphoblastic leukemia.
    Buitenkamp TD; Mathôt RA; de Haas V; Pieters R; Zwaan CM
    Haematologica; 2010 Jul; 95(7):1106-13. PubMed ID: 20418240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute lymphoblastic leukaemia in children with Down syndrome: an updated review.
    Maloney KW
    Br J Haematol; 2011 Nov; 155(4):420-5. PubMed ID: 21933171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis of Down's syndrome with acute leukaemia.
    Levitt GA; Stiller CA; Chessells JM
    Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute leukemia in patients with Down syndrome].
    Fernández-Plaza S; Sevilla J; Contra T; Martín N; Madero L
    An Pediatr (Barc); 2004 Dec; 61(6):515-9. PubMed ID: 15574252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired acrodermatitis enteropathica during chemotherapy for acute lymphocytic leukaemia in a child with Down syndrome.
    Sawai T; Sugiura H; Danno K; Uchiyama M; Ohta S
    Br J Dermatol; 1996 Oct; 135(4):659-60. PubMed ID: 8915175
    [No Abstract]   [Full Text] [Related]  

  • 14. [Early diagnosis of leukaemia in the trisomic child. Congolese experience based on two cases].
    Mouko A; Nkanta-Etokabeka F; Senga P
    Bull Soc Pathol Exot; 2004 May; 97(2):115-6. PubMed ID: 15255354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight-based dose calculation.
    Jönsson P; Skärby T; Heldrup J; Schrøder H; Höglund P
    Pediatr Blood Cancer; 2011 Jul; 57(1):41-6. PubMed ID: 21425443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anthracyclines for acute lymphoblastic leukemia in a child with congenital long QT syndrome.
    Sasase S; Yoshida H; Matsumura R; Miyashita E; Hashii Y; Ohta H; Maekawa S; Kogaki S; Ozono K
    Int J Hematol; 2011 Jun; 93(6):802-805. PubMed ID: 21512729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate sensitivity in Down's syndrome: a hypothesis.
    Ueland PM; Refsum H; Christensen B
    Cancer Chemother Pharmacol; 1990; 25(5):384-6. PubMed ID: 2137726
    [No Abstract]   [Full Text] [Related]  

  • 20. Physicians compliance during maintenance therapy in children with Down syndrome and acute lymphoblastic leukemia.
    Bohnstedt C; Levinsen M; Rosthøj S; Zeller B; Taskinen M; Hafsteinsdottir S; Björgvinsdóttir H; Heyman M; Schmiegelow K;
    Leukemia; 2013 Apr; 27(4):866-70. PubMed ID: 23138181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.